1492 Capital Management’s MiMedx Group MDXG Stock Holding History

1492 Capital Management’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-56,540	Closed	-$713K	–	94
2017 Q4	$713K	Sell	56,540 -448	-0.8%	-$5.46K	0.56%	58
2017 Q3	$677K	Sell	56,988 -135	-0.2%	-$2K	0.6%	52
2017 Q2	$855K	Sell	57,123 -12,420	-18%	-$166K	0.75%	42
2017 Q1	$663K	Buy	69,543 +16,997	+32%	+$144K	0.52%	48
2016 Q4	$466K	Sell	52,546 -2,134	-4%	-$19.2K	0.36%	67
2016 Q3	$469K	Buy	54,680 +13,523	+33%	+$107K	0.38%	59
2016 Q2	$328K	Sell	41,157 -3,982	-9%	-$31K	0.29%	70
2016 Q1	$395K	Sell	45,139 -1,592	-3%	-$13.2K	0.33%	65
2015 Q4	$438K	Sell	46,731 -4,263	-8%	-$36.9K	0.32%	69
2015 Q3	$492K	Buy	+50,994	New	+$538K	0.35%	73

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

1492 Capital Management's MDXG Position: Q1 2018 in Review

1492 Capital Management sold out of MiMedx Group (MDXG) in Q1 2018, closing a stake of 56,540 shares — an estimated $713K sold.

1492 Capital Management first reported a position in MDXG in Q3 2015 and held it in 10 quarters. The position peaked at $855K in Q2 2017. 223 funds tracked by Wall St. Rank hold MDXG as of Q1 2018.

1492 Capital Management reported no remaining MiMedx Group position as of Q1 2018 after selling out during the quarter.
1492 Capital Management sold 56,540 MiMedx Group shares in Q1 2018, an estimated $713K.
1492 Capital Management first reported a position in MiMedx Group in Q3 2015 and held it in 10 quarters.
1492 Capital Management's MiMedx Group position peaked at $855K in Q2 2017.
223 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2018.

Based on 1492 Capital Management's 13F filing for Q1 2018, filed 14 May 2018.